TrendPeek
Business

What Happened to terns pharmaceuticals?

Overview

Terns Pharmaceuticals is trending today following news of a significant acquisition by Merck & Co. The pharmaceutical giant is reportedly set to acquire Terns for billions to enhance its oncology drug pipeline.

What the News Says

1

Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline

CNBC
2

Merck inks $5.7B Terns Pharma takeover

Axios
3

Merck seals $5.7bn biotech deal to boost cancer drug pipeline

Financial Times

Get the full breakdown — why it matters, background context, and what comes next.

Read Full Analysis